Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LUCID DIAGNOSTICS INC.

(LUCD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Moderate Slightly in Afternoon Trading

10/14/2021 | 03:43pm EST


ę MT Newswires 2021
All news about LUCID DIAGNOSTICS INC.
01/20LUCID DIAGNOSTICS INC. : Change in Directors or Principal Officers, Financial Statements a..
AQ
01/12PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team
BU
01/07LUCID DIAGNOSTICS : to Participate in a Fireside Chat at the 24th Annual Needham Virtual G..
PU
01/07LUCID DIAGNOSTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
2021Ascendiant Capital Starts Lucid Diagnostics at Buy With $16 Price Target
MT
2021LUCID DIAGNOSTICS INC.(NASDAQGM : LUCD) added to S&P TMI Index
CI
2021Needham Lowers Lucid Diagnostics' Price Target to $13 From $17, Citing 'Peer Multiple C..
MT
2021LUCID DIAGNOSTICS : PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Pro..
PU
2021LUCID DIAGNOSTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
2021Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHe..
CI
More news
Analyst Recommendations on LUCID DIAGNOSTICS INC.
More recommendations
Financials (USD)
Sales 2021 0,60 M - -
Net income 2021 -23,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -2,82x
Yield 2021 -
Capitalization 142 M 142 M -
Capi. / Sales 2021 237x
Capi. / Sales 2022 22,9x
Nbr of Employees -
Free-Float -
Chart LUCID DIAGNOSTICS INC.
Duration : Period :
Lucid Diagnostics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LUCID DIAGNOSTICS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 3,86 $
Average target price 16,40 $
Spread / Average Target 325%
EPS Revisions
Managers and Directors
Lishan Aklog Executive Chairman & Chief Executive Officer
Dennis M. McGrath Chief Financial Officer & Director
David F. Wurtman Chief Medical Officer
Suman M. Verma Chief Scientific Officer
Randy Brown Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
LUCID DIAGNOSTICS INC.-28.12%142
MASIMO CORPORATION-23.75%12 328
GETINGE AB-16.05%9 932
PENUMBRA, INC.-23.90%8 168
NOVOCURE LIMITED-6.63%6 663
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.-14.52%5 134